Biofrontera Inc.
BFRINasdaqCIK 1858685HealthcareFiscal year ends Dec 31
Reports and events: 164 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1409:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-042508 |
| 2026-08-1316:41 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037834 |
| 2026-08-1309:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037610 |
| 2026-07-2216:40 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-034251 |
| 2026-06-1716:05 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-029079 |
| 2026-05-1416:28 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023119 |
| 2026-05-1408:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022875 |
| 2026-04-3016:40 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001493152-26-020616 |
| 2026-03-1916:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-011625 |
| 2026-03-1909:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-011545 |
| 2026-03-0909:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-009321 |
| 2026-02-2609:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-008136 |
| 2026-02-0909:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-005717 |
| 2026-01-1308:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-001959 |
| 2026-01-0716:30 ET | 8-K | 3.01 Delisting notice | 0001493152-26-000823 |
| 2025-12-0517:15 ET | S-1 | Registration statement | 0001493152-25-026443 |
| 2025-11-1308:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022133 |
| 2025-11-1216:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021945 |
| 2025-11-1016:30 ET | 8-K | 8.01 Other events | 0001493152-25-021525 |
| 2025-11-0708:05 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-021189 |
| 2025-10-2417:29 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-019370 |
| 2025-10-2308:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-019006 |
| 2025-09-1916:45 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-014281 |
| 2025-09-1915:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-089466 |
| 2025-08-1317:30 ET | S-1/A | Registration statement, amended | 0001641172-25-023615 |
| 2025-08-1317:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023598 |
| 2025-08-1316:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-023486 |
| 2025-08-1117:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023006 |
| 2025-08-0516:15 ET | DEF 14A | Proxy statementPeriod 2025-08-05 | 0001641172-25-022261 |
| 2025-07-2514:31 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-067663 |
| 2025-07-1617:28 ET | S-1 | Registration statement | 0001641172-25-019928 |
| 2025-07-1616:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001641172-25-019884 |
| 2025-07-0108:55 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-017285 |
| 2025-06-3008:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017052 |
| 2025-06-1816:15 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-015584 |
| 2025-06-1115:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-014674 |
| 2025-06-0317:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-013491 |
| 2025-05-2316:30 ET | 8-K | 3.01 Delisting notice | 0001641172-25-012285 |
| 2025-05-1517:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-011069 |
| 2025-05-1516:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-011031 |
| 2025-05-1416:52 ET | 8-K | 3.01 Delisting notice | 0001641172-25-010330 |
| 2025-04-3016:15 ET | DEF 14A | Proxy statementPeriod 2025-04-30 | 0001641172-25-007772 |
| 2025-04-1816:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-005428 |
| 2025-03-2108:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-011083 |
| 2025-03-2017:18 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-011052 |
| 2025-01-1709:24 ET | S-1 | Registration statement | 0001493152-25-002844 |
| 2024-12-2012:40 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-24-110979 |
| 2024-11-2709:26 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-24-047928 |
| 2024-11-2209:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-047306 |
| 2024-11-1418:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045220 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.